EZH2 and cervical carcinoma: In this study, among the various prognostically important clinicopathological variables that were analyzed with regard to EZH2 immunoexpression, it was observed that higher FIGO stage of carcinoma cervix showed high immunoexpression score of EZH2 with statistical significance (p = 0.031) (Table 2) which was in concordance with the study done by Zhang et al. who studied 168 cases of cervical SCC of different FIGO stages and observed increasing EZH2 expression with ascending stages of SCC with statistical significance (p < 0.05) [20].